Pathology/Lab Coding Alert

Reader Question:

G0431 or G0434 Could Describe Immunoassay

Question: Our lab performs an immunoassay drug screen for six drug classes for a Medicare beneficiary, and we have CLIA certification for high-complexity tests. Should we bill G0431?Louisiana SubscriberAnswer: The correct code depends on the complexity of the test you perform, not on your CLIA certification level (assuming you're approved for the level and type of test you perform). Immunoassay drug screens can be moderate or high complexity, depending on the manufacturer and/or instrumentation. For the work you describe for Medicare coverage, you should report one of the following codes depending on the complexity of the test:G0431 -- Drug screen, qualitative; multiple drug classes by high complexity test method (e.g., immunoassay, enzyme assay), per patient encounterG0434 -- Drug screen, other than chromatographic; any number of drug classes, by CLIA waived test or moderate complexity test, per patient encounterWatch reimbursement: You don't want to make n $82 mistake by billing a high-complexity test [...]
You’ve reached your limit of free articles. Already a subscriber? Log in.
Not a subscriber? Subscribe today to continue reading this article. Plus, you’ll get:
  • Simple explanations of current healthcare regulations and payer programs
  • Real-world reporting scenarios solved by our expert coders
  • Industry news, such as MAC and RAC activities, the OIG Work Plan, and CERT reports
  • Instant access to every article ever published in your eNewsletter
  • 6 annual AAPC-approved CEUs*
  • The latest updates for CPT®, ICD-10-CM, HCPCS Level II, NCCI edits, modifiers, compliance, technology, practice management, and more
*CEUs available with select eNewsletters.

Other Articles in this issue of

Pathology/Lab Coding Alert

View All